z-logo
Premium
Graves' Ophthalmopathy: Comparison of the Doppler sonography parameters with the clinical activity score
Author(s) -
Yanik Bahar,
Conkbayir Işik,
Acaroglu Golge,
Hekimoglu Baki
Publication year - 2005
Publication title -
journal of clinical ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.272
H-Index - 61
eISSN - 1097-0096
pISSN - 0091-2751
DOI - 10.1002/jcu.20154
Subject(s) - medicine , graves' ophthalmopathy , central retinal artery , ophthalmic artery , ultrasonography , group b , graves' disease , diastole , retinal artery , color doppler , central retinal vein , cardiology , blood flow , doppler sonography , vein , ultrasound , doppler effect , doppler ultrasound , artery , ophthalmology , surgery , retinal , radiology , disease , blood pressure , physics , astronomy
Purpose . Our aim was to compare the Doppler ultrasonography (US) parameters with clinical activity score (CAS) in patients with Graves' ophthalmopathy.Methods . Blood flow parameters in the ophthalmic artery (OA), superior ophthalmic vein (SOV), central retinal artery (CRA) and central retinal vein (CRV) were measured by Doppler US in 118 patients with Graves' disease in 3 groups (A, B, and C) and 20 control subjects. Group A included 25 patients with CAS value “0”; group B 55 patients with CAS value “1 or 2”; group C 38 patients with CAS value “3 or above.”Results . Peak systolic velocities (PSV) and end‐diastolic velocities (EDV) in the OA, PSV, and in the CRA calculated for group C were significantly higher than for group A, group B, and the control group. Resistance index in the OA and maximal velocity (MV) in the SOV calculated for group C were significantly lower than those calculated for group A, group B, and the control group.Conclusion . Doppler parameters of MV in SOV, PSV and EDV in OA, and PSV in CRA seem to be helpful in the differentiation of active and inactive phases of Graves' ophthalmopathy. © 2005 Wiley Periodicals, Inc. J Clin Ultrasound 33 :375–380, 2005

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here